Literature DB >> 6360335

Immunocytochemistry of neurotropic melanoma.

T F Warner, R V Lloyd, G R Hafez, J M Angevine.   

Abstract

Schwann cell differentiation has been proposed in the histogenesis of neurotropic melanoma by light and electron microscopic studies, and melanosomes are rarely, if ever, detected in the spindle cell component of this tumor. S-100 immunoreactivity has previously been demonstrated in Schwann cells of benign neurogenic tumors and most malignant melanomas. The authors report S-100 immunoreactivity in spindle cell elements of neurotropic melanoma. Focal neuron-specific enolase immunoreactivity was also found. These findings, in the absence of melanosomes in tumor cells, support the contention that the spindle cell element of neurotropic melanoma is derived from cells of neural crest origin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360335     DOI: 10.1002/1097-0142(19840115)53:2<254::aid-cncr2820530212>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Diagnostic immunopathology.

Authors:  P A Cancilla; A J Cochran; F Naeim; J W Said
Journal:  West J Med       Date:  1986-07

2.  Melanotic schwannoma of the sympathetic ganglia: a histologic, immunohistochemical and ultrastructural study.

Authors:  C Di Bella; P Declich; A Assi; G Cenacchi; M Sironi; L Cozzi; A Griner
Journal:  J Neurooncol       Date:  1997-11       Impact factor: 4.130

Review 3.  Neurotropic melanoma. A case report and review of the literature.

Authors:  E E Mack; E C Gomez
Journal:  J Neurooncol       Date:  1992-06       Impact factor: 4.130

4.  Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.

Authors:  M Leader; M Collins; J Patel; K Henry
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

5.  Neurotropic malignant melanoma of right temple with orbital metastasis: a clinicopathological case report.

Authors:  M K Khalil; W P Duguid
Journal:  Br J Ophthalmol       Date:  1987-01       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.